Corneal Implants Market By Type (Artificial Cornea and Human Cornea); By Disease Indication (Keratoconus, Myopia, Fuchs' Dystrophy, Infectious Cornea, and Others); By Procedure (Penetrating Keratoplasty (PK) and Endothelial Keratoplasty (EK)); By End-Users (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Others); By Region (North America (U.S., Canada, Mexico, Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Denmark, Finland, Iceland, Sweden, Norway, Belgium, The Netherlands, Luxembourg, Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia) Rest of Asia Pacific), Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2021 – 2029
Industry Trends
The number of blind people worldwide is not known accurately. However, according to the data published by World Health Organization's (WHO), in 2021, about one billion people globally had modest or severe distance vision impairment or blindness due to cataract, unaddressed refractive error, diabetic retinopathy, corneal opacities, glaucoma, trachoma, and near vision damage caused by unaddressed presbyopia. The rising number of people suffering from ophthalmic diseases is likely to support the positive growth of the market. Several scientific studies identified three main reasons for blindness, i.e., cataract, trachoma, and glaucoma. Hence, the corneal disease is the second most significant cause of blindness, apart from cataracts. Visual rehabilitation of these cases is possible with corneal transplantation, which is likely to drive the global corneal implants market in the upcoming period.
Moreover, in the absence of aggressive interventions, blindness can continue to surge by nearly 2 million every year owing to the aging and increasing population and service delivery not keeping pace with the incidence. This gap between the supply and demand of corneal implants is expected to positively impact the market growth in the forthcoming years. Population growth and aging are the major factors driving the corneal implants market growth in several developed as well as developing regions.
The risk of spreading infectious viruses and diseases is an important aspect of corneal transplantation that can affect recipients or those handling donor tissue. Therefore, the sudden outburst of a novel coronavirus has negatively impacted the corneal transplantation industry worldwide. Moreover, curtailed elective procedures and travel restrictions have reduced corneal transplantation supply, retrieval, and demand. However, there is no actual evidence showcasing the transmission of the Covid-19 virus through corneal transplantation procedures. Healthcare providers are undertaking initiatives to reinstate the implant procedures seamlessly and ensuring that all safety protocols are implemented. The United Kingdom National Health Service (NHS) for example, has laid down series of tests to be carried out before the procedure. Hence, medical professionals at large are closely analysing multiple aspects before beginning the procedures.
In terms of revenue, the global corneal implants market was valued at US$ 394.69 Mn in 2020, growing at a CAGR of 6.8% over the forecast period (2021 – 2029). The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries.
Global Corneal Implants Market Revenue & Forecast, (US$ Million), 2015 – 2029
Type Outlook:
Based on type, the corneal implants market has been segmented into artificial cornea and human cornea. The human cornea segment held a significant share in the market. In general, artificial corneal implantation involves a long-term topical and sometimes oral treatment to treat complications such as glaucoma and infections. Close postoperative follow-up is mandatory in artificial corneal transplants due to the high risk of complications, which can sometimes lead to permanent blindness, mainly endophthalmitis and retinal detachment. Moreover, corneal melting and infection rates are comparatively lower with donor transplantation than with artificial devices. The rates of vision-threatening complications are lower in donor corneal transplantation cases, which is expected to increase demand, thereby supporting the segment growth.
By Disease Indication Outlook:
Based on disease indication, the global corneal implants market has been segmented into keratoconus, myopia, Fuchs' dystrophy, infectious cornea, and others. Currently, Fuchs' dystrophy segment holds the leading position, and it will remain dominant throughout the forecast period. The growing awareness amongst the population regarding the early disease diagnosis and increasing prevalence of fuchs' dystrophy are driving the segment growth. Moreover, according to the data published by, The National Center for Biotechnology Information (NCBI), myopia is one of the significant causes of visual impairment globally, affecting approximately 27-30% of the world's population. The number of people with myopia is anticipated to rise both as a percentage of the population and in absolute numbers. In specific age groups in numerous Asian countries, the prevalence of myopia is over 70-75%. Among late teenagers and young adults in China, Korea, and Taiwan, the prevalence is now between 84% and 97%. Furthermore, the infectious cornea is a major global cause of visual impairment and blindness, often affecting marginalized populations.
Procedure Outlook:
Based on procedure, the global corneal implants market has been segmented into penetrating keratoplasty (PK) and endothelial keratoplasty (EK). In 2020, the penetrating keratoplasty (PK) accounted for the largest share in the market as the lymphogenic and immunological privilege of the avascular cornea, penetrating keratoplasty is the most successful tissue transplantation procedure currently performed in humans. The high success rate associated with this procedure is anticipated to further drive the segment growth.
End-Users Outlook:
Based on end-users, the global corneal implants market has been segmented into hospitals, specialty clinics, ambulatory surgical centers, and others. The rate of cornea implant surgery in hospitals is high compared to the other end-users, and the segment is anticipated to hold its leading position throughout the forecast period. The presence of highly skilled doctors and medical professionals, the increasing number of patients, and access to transnational eye banks are the major factors supporting the segment's growth.
Region Outlook:
Based on the regions, North America accounted for a prominent share in the global corneal implants market. The availability of well-established health care facilities, high expenditure capacity of the American consumers, and the rising prevalence of vision impairment due to the increasing aging population are some of the major factors supporting the region’s growth in the global market.
Competitive Landscape:
The report provides both qualitative and quantitative research of the global corneal implants market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification, amongst others.
Some of the key players operating in the global corneal implants market are:
- AJL Ophthalmic, S.A.
- Aurolab
- CorneaGen
- CorNeat Vision
- EyeYon Medical
- L V PRASAD EYE INSTITUTE
- LinkoCare Life Sciences AB
- Presbia PLC
- SightLife
- Swissmed Pte Ltd
- Other Market Participants
Global Corneal Implants Market:
- By Type
- Artificial Cornea
- Human Cornea
- By Disease Indication
- Keratoconus
- Myopia
- Fuchs' Dystrophy
- Infectious Cornea
- Others
- By Procedure Type
- Penetrating Keratoplasty (PK)
- Endothelial Keratoplasty (EK)
- By End Users
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
- Others
- By Region
- North America
- S.
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
- North America
Table of Contents
1. Market Scope
1.1. Market
Segmentation
1.2. Years
Considered
1.2.1. Historic
Years: 2015 - 2019
1.2.2. Base
Year: 2020
1.2.3. Forecast
Years: 2021 – 2029
2. Key Target Audiences
3. Research Methodology
3.1. Primary
Research
3.1.1. Research
Questionnaire
3.1.2. Global
Percentage Breakdown
3.1.3. Primary
Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary
Research
3.2.1. Paid
Databases
3.2.2. Secondary
Sources
3.3. Market
Size Estimates
3.3.1. Top-Down
Approach
3.3.2. Bottom-Up
Approach
3.4. Data
Triangulation Methodology
3.5. Research
Assumptions
4. Recommendations and Insights from AMI’s Perspective**
5. Holistic Overview of Corneal Implants Market
6. Market Synopsis:
Corneal Implants Market
7. Corneal Implants Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product
Definition
7.1.2. Industry
Development
7.2. Market Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.3. Trends in
Corneal Implants Market
7.4. Market
Determinants Radar Chart
7.5. Macro-Economic
and Micro-Economic Indicators: Corneal Implants Market
7.6. Porter’s
Five Force Analysis
8. Global Corneal Implants Market Analysis and Forecasts, 2021 –
2029
8.1. Overview
8.1.1. Global
Corneal Implants Market Revenue (US$ Mn)
8.2. Global
Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Type
8.2.1. Artificial
Cornea
8.2.1.1. Definition
8.2.1.2. Market Estimation and Penetration, 2015 - 2020
8.2.1.3. Market Forecast, 2021 - 2029
8.2.1.4. Compound Annual Growth Rate (CAGR)
8.2.1.5. Regional Bifurcation
8.2.1.5.1. North America
8.2.1.5.1.1. Market
Estimation, 2015 - 2020
8.2.1.5.1.2. Market
Forecast, 2021 - 2029
8.2.1.5.2. Europe
8.2.1.5.2.1. Market
Estimation, 2015 - 2020
8.2.1.5.2.2. Market
Forecast, 2021 - 2029
8.2.1.5.3. Asia Pacific
8.2.1.5.3.1. Market
Estimation, 2015 - 2020
8.2.1.5.3.2. Market
Forecast, 2021 - 2029
8.2.1.5.4. Middle East and Africa
8.2.1.5.4.1. Market
Estimation, 2015 - 2020
8.2.1.5.4.2. Market
Forecast, 2021 - 2029
8.2.1.5.5. Latin America
8.2.1.5.5.1. Market
Estimation, 2015 - 2020
8.2.1.5.5.2. Market
Forecast, 2021 - 2029
8.2.2. Human
Cornea
8.2.2.1. Definition
8.2.2.2. Market Estimation and Penetration, 2015 - 2020
8.2.2.3. Market Forecast, 2021 - 2029
8.2.2.4. Compound Annual Growth Rate (CAGR)
8.2.2.5. Regional Bifurcation
8.2.2.5.1. North America
8.2.2.5.1.1. Market
Estimation, 2015 - 2020
8.2.2.5.1.2. Market
Forecast, 2021 - 2029
8.2.2.5.2. Europe
8.2.2.5.2.1. Market
Estimation, 2015 - 2020
8.2.2.5.2.2. Market
Forecast, 2021 - 2029
8.2.2.5.3. Asia Pacific
8.2.2.5.3.1. Market
Estimation, 2015 - 2020
8.2.2.5.3.2. Market
Forecast, 2021 - 2029
8.2.2.5.4. Middle East and Africa
8.2.2.5.4.1. Market
Estimation, 2015 - 2020
8.2.2.5.4.2. Market
Forecast, 2021 - 2029
8.2.2.5.5. Latin America
8.2.2.5.5.1. Market
Estimation, 2015 - 2020
8.2.2.5.5.2. Market
Forecast, 2021 - 2029
8.3. Key
Segment for Channeling Investments
8.3.1. By Type
9. Global Corneal Implants Market Analysis and Forecasts, 2021 –
2029
9.1. Overview
9.2. Global
Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Disease Indication
9.2.1. Keratoconus
9.2.1.1. Definition
9.2.1.2. Market Estimation and Penetration, 2015 - 2020
9.2.1.3. Market Forecast, 2021 - 2029
9.2.1.4. Compound Annual Growth Rate (CAGR)
9.2.1.5. Regional Bifurcation
9.2.1.5.1. North America
9.2.1.5.1.1. Market
Estimation, 2015 - 2020
9.2.1.5.1.2. Market
Forecast, 2021 - 2029
9.2.1.5.2. Europe
9.2.1.5.2.1. Market
Estimation, 2015 - 2020
9.2.1.5.2.2. Market
Forecast, 2021 - 2029
9.2.1.5.3. Asia Pacific
9.2.1.5.3.1. Market
Estimation, 2015 - 2020
9.2.1.5.3.2. Market
Forecast, 2021 - 2029
9.2.1.5.4. Middle East and Africa
9.2.1.5.4.1. Market
Estimation, 2015 - 2020
9.2.1.5.4.2. Market
Forecast, 2021 - 2029
9.2.1.5.5. Latin America
9.2.1.5.5.1. Market
Estimation, 2015 - 2020
9.2.1.5.5.2. Market
Forecast, 2021 - 2029
9.2.2. Myopia
9.2.2.1. Definition
9.2.2.2. Market Estimation and Penetration, 2015 - 2020
9.2.2.3. Market Forecast, 2021 - 2029
9.2.2.4. Compound Annual Growth Rate (CAGR)
9.2.2.5. Regional Bifurcation
9.2.2.5.1. North America
9.2.2.5.1.1. Market
Estimation, 2015 - 2020
9.2.2.5.1.2. Market
Forecast, 2021 - 2029
9.2.2.5.2. Europe
9.2.2.5.2.1. Market
Estimation, 2015 - 2020
9.2.2.5.2.2. Market
Forecast, 2021 - 2029
9.2.2.5.3. Asia Pacific
9.2.2.5.3.1. Market
Estimation, 2015 - 2020
9.2.2.5.3.2. Market
Forecast, 2021 - 2029
9.2.2.5.4. Middle East and Africa
9.2.2.5.4.1. Market
Estimation, 2015 - 2020
9.2.2.5.4.2. Market
Forecast, 2021 - 2029
9.2.2.5.5. Latin America
9.2.2.5.5.1. Market
Estimation, 2015 - 2020
9.2.2.5.5.2. Market
Forecast, 2021 - 2029
9.2.3. Fuchs'
Dystrophy
9.2.3.1. Definition
9.2.3.2. Market Estimation and Penetration, 2015 - 2020
9.2.3.3. Market Forecast, 2021 - 2029
9.2.3.4. Compound Annual Growth Rate (CAGR)
9.2.3.5. Regional Bifurcation
9.2.3.5.1. North America
9.2.3.5.1.1. Market
Estimation, 2015 - 2020
9.2.3.5.1.2. Market
Forecast, 2021 - 2029
9.2.3.5.2. Europe
9.2.3.5.2.1. Market
Estimation, 2015 - 2020
9.2.3.5.2.2. Market
Forecast, 2021 - 2029
9.2.3.5.3. Asia Pacific
9.2.3.5.3.1. Market
Estimation, 2015 - 2020
9.2.3.5.3.2. Market
Forecast, 2021 - 2029
9.2.3.5.4. Middle East and Africa
9.2.3.5.4.1. Market
Estimation, 2015 - 2020
9.2.3.5.4.2. Market
Forecast, 2021 - 2029
9.2.3.5.5. Latin America
9.2.3.5.5.1. Market
Estimation, 2015 - 2020
9.2.3.5.5.2. Market
Forecast, 2021 - 2029
9.2.4. Infectious
Cornea
9.2.4.1. Definition
9.2.4.2. Market Estimation and Penetration, 2015 - 2020
9.2.4.3. Market Forecast, 2021 - 2029
9.2.4.4. Compound Annual Growth Rate (CAGR)
9.2.4.5. Regional Bifurcation
9.2.4.5.1. North America
9.2.4.5.1.1. Market
Estimation, 2015 - 2020
9.2.4.5.1.2. Market
Forecast, 2021 - 2029
9.2.4.5.2. Europe
9.2.4.5.2.1. Market
Estimation, 2015 - 2020
9.2.4.5.2.2. Market
Forecast, 2021 - 2029
9.2.4.5.3. Asia Pacific
9.2.4.5.3.1. Market
Estimation, 2015 - 2020
9.2.4.5.3.2. Market
Forecast, 2021 - 2029
9.2.4.5.4. Middle East and Africa
9.2.4.5.4.1. Market
Estimation, 2015 - 2020
9.2.4.5.4.2. Market
Forecast, 2021 - 2029
9.2.4.5.5. Latin America
9.2.4.5.5.1. Market
Estimation, 2015 - 2020
9.2.4.5.5.2. Market
Forecast, 2021 - 2029
9.2.5. Others
9.2.5.1. Definition
9.2.5.2. Market Estimation and Penetration, 2015 - 2020
9.2.5.3. Market Forecast, 2021 - 2029
9.2.5.4. Compound Annual Growth Rate (CAGR)
9.2.5.5. Regional Bifurcation
9.2.5.5.1. North America
9.2.5.5.1.1. Market
Estimation, 2015 - 2020
9.2.5.5.1.2. Market
Forecast, 2021 - 2029
9.2.5.5.2. Europe
9.2.5.5.2.1. Market
Estimation, 2015 - 2020
9.2.5.5.2.2. Market
Forecast, 2021 - 2029
9.2.5.5.3. Asia Pacific
9.2.5.5.3.1. Market
Estimation, 2015 - 2020
9.2.5.5.3.2. Market
Forecast, 2021 - 2029
9.2.5.5.4. Middle East and Africa
9.2.5.5.4.1. Market
Estimation, 2015 - 2020
9.2.5.5.4.2. Market
Forecast, 2021 - 2029
9.2.5.5.5. Latin America
9.2.5.5.5.1. Market
Estimation, 2015 - 2020
9.2.5.5.5.2. Market
Forecast, 2021 - 2029
9.3. Key
Segment for Channeling Investments
9.3.1. By
Disease Indication
10. Global Corneal Implants Market Analysis and Forecasts, 2021 –
2029
10.1. Overview
10.2. Global
Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Procedure Type
10.2.1. Penetrating
Keratoplasty (PK)
10.2.1.1. Definition
10.2.1.2. Market Estimation and Penetration, 2015 - 2020
10.2.1.3. Market Forecast, 2021 - 2029
10.2.1.4. Compound Annual Growth Rate (CAGR)
10.2.1.5. Regional Bifurcation
10.2.1.5.1. North America
10.2.1.5.1.1. Market
Estimation, 2015 - 2020
10.2.1.5.1.2. Market
Forecast, 2021 - 2029
10.2.1.5.2. Europe
10.2.1.5.2.1. Market
Estimation, 2015 - 2020
10.2.1.5.2.2. Market
Forecast, 2021 - 2029
10.2.1.5.3. Asia Pacific
10.2.1.5.3.1. Market
Estimation, 2015 - 2020
10.2.1.5.3.2. Market
Forecast, 2021 - 2029
10.2.1.5.4. Middle East and Africa
10.2.1.5.4.1. Market
Estimation, 2015 - 2020
10.2.1.5.4.2. Market
Forecast, 2021 - 2029
10.2.1.5.5. Latin America
10.2.1.5.5.1. Market
Estimation, 2015 - 2020
10.2.1.5.5.2. Market
Forecast, 2021 - 2029
10.2.2. Endothelial
Keratoplasty (EK)
10.2.2.1. Definition
10.2.2.2. Market Estimation and Penetration, 2015 - 2020
10.2.2.3. Market Forecast, 2021 - 2029
10.2.2.4. Compound Annual Growth Rate (CAGR)
10.2.2.5. Regional Bifurcation
10.2.2.5.1. North America
10.2.2.5.1.1. Market
Estimation, 2015 - 2020
10.2.2.5.1.2. Market
Forecast, 2021 - 2029
10.2.2.5.2. Europe
10.2.2.5.2.1. Market
Estimation, 2015 - 2020
10.2.2.5.2.2. Market
Forecast, 2021 - 2029
10.2.2.5.3. Asia Pacific
10.2.2.5.3.1. Market
Estimation, 2015 - 2020
10.2.2.5.3.2. Market
Forecast, 2021 - 2029
10.2.2.5.4. Middle East and Africa
10.2.2.5.4.1. Market
Estimation, 2015 - 2020
10.2.2.5.4.2. Market
Forecast, 2021 - 2029
10.2.2.5.5. Latin America
10.2.2.5.5.1. Market
Estimation, 2015 - 2020
10.2.2.5.5.2. Market
Forecast, 2021 - 2029
10.3. Key
Segment for Channeling Investments
10.3.1. By
Procedure Type
11. Global Corneal Implants Market Analysis and Forecasts, 2021 –
2029
11.1. Overview
11.2. Global
Corneal Implants Market Revenue (US$ Mn) and Forecasts, By End Users
11.2.1. Hospitals
11.2.1.1. Definition
11.2.1.2. Market Estimation and Penetration, 2015 - 2020
11.2.1.3. Market Forecast, 2021 - 2029
11.2.1.4. Compound Annual Growth Rate (CAGR)
11.2.1.5. Regional Bifurcation
11.2.1.5.1. North America
11.2.1.5.1.1. Market
Estimation, 2015 - 2020
11.2.1.5.1.2. Market
Forecast, 2021 - 2029
11.2.1.5.2. Europe
11.2.1.5.2.1. Market
Estimation, 2015 - 2020
11.2.1.5.2.2. Market
Forecast, 2021 - 2029
11.2.1.5.3. Asia Pacific
11.2.1.5.3.1. Market
Estimation, 2015 - 2020
11.2.1.5.3.2. Market
Forecast, 2021 - 2029
11.2.1.5.4. Middle East and Africa
11.2.1.5.4.1. Market
Estimation, 2015 - 2020
11.2.1.5.4.2. Market
Forecast, 2021 - 2029
11.2.1.5.5. Latin America
11.2.1.5.5.1. Market
Estimation, 2015 - 2020
11.2.1.5.5.2. Market
Forecast, 2021 - 2029
11.2.2. Specialty
Clinics
11.2.2.1. Definition
11.2.2.2. Market Estimation and Penetration, 2015 - 2020
11.2.2.3. Market Forecast, 2021 - 2029
11.2.2.4. Compound Annual Growth Rate (CAGR)
11.2.2.5. Regional Bifurcation
11.2.2.5.1. North America
11.2.2.5.1.1. Market
Estimation, 2015 - 2020
11.2.2.5.1.2. Market
Forecast, 2021 - 2029
11.2.2.5.2. Europe
11.2.2.5.2.1. Market
Estimation, 2015 - 2020
11.2.2.5.2.2. Market
Forecast, 2021 - 2029
11.2.2.5.3. Asia Pacific
11.2.2.5.3.1. Market
Estimation, 2015 - 2020
11.2.2.5.3.2. Market
Forecast, 2021 - 2029
11.2.2.5.4. Middle East and Africa
11.2.2.5.4.1. Market
Estimation, 2015 - 2020
11.2.2.5.4.2. Market
Forecast, 2021 - 2029
11.2.2.5.5. Latin America
11.2.2.5.5.1. Market
Estimation, 2015 - 2020
11.2.2.5.5.2. Market
Forecast, 2021 - 2029
11.2.3. Ambulatory
Surgical Centers
11.2.3.1. Definition
11.2.3.2. Market Estimation and Penetration, 2015 - 2020
11.2.3.3. Market Forecast, 2021 - 2029
11.2.3.4. Compound Annual Growth Rate (CAGR)
11.2.3.5. Regional Bifurcation
11.2.3.5.1. North America
11.2.3.5.1.1. Market
Estimation, 2015 - 2020
11.2.3.5.1.2. Market
Forecast, 2021 - 2029
11.2.3.5.2. Europe
11.2.3.5.2.1. Market
Estimation, 2015 - 2020
11.2.3.5.2.2. Market
Forecast, 2021 - 2029
11.2.3.5.3. Asia Pacific
11.2.3.5.3.1. Market
Estimation, 2015 - 2020
11.2.3.5.3.2. Market
Forecast, 2021 - 2029
11.2.3.5.4. Middle East and Africa
11.2.3.5.4.1. Market
Estimation, 2015 - 2020
11.2.3.5.4.2. Market
Forecast, 2021 - 2029
11.2.3.5.5. Latin America
11.2.3.5.5.1. Market
Estimation, 2015 - 2020
11.2.3.5.5.2. Market
Forecast, 2021 - 2029
11.2.4. Others
11.2.4.1. Definition
11.2.4.2. Market Estimation and Penetration, 2015 - 2020
11.2.4.3. Market Forecast, 2021 - 2029
11.2.4.4. Compound Annual Growth Rate (CAGR)
11.2.4.5. Regional Bifurcation
11.2.4.5.1. North America
11.2.4.5.1.1. Market
Estimation, 2015 - 2020
11.2.4.5.1.2. Market
Forecast, 2021 - 2029
11.2.4.5.2. Europe
11.2.4.5.2.1. Market
Estimation, 2015 - 2020
11.2.4.5.2.2. Market
Forecast, 2021 - 2029
11.2.4.5.3. Asia Pacific
11.2.4.5.3.1. Market
Estimation, 2015 - 2020
11.2.4.5.3.2. Market
Forecast, 2021 - 2029
11.2.4.5.4. Middle East and Africa
11.2.4.5.4.1. Market
Estimation, 2015 - 2020
11.2.4.5.4.2. Market
Forecast, 2021 - 2029
11.2.4.5.5. Latin America
11.2.4.5.5.1. Market
Estimation, 2015 - 2020
11.2.4.5.5.2. Market
Forecast, 2021 - 2029
11.3. Key
Segment for Channeling Investments
11.3.1. By End
Users
12. North America Corneal Implants Market Analysis and Forecasts,
2021 - 2029
12.1. Overview
12.1.1. North
America Corneal Implants Market Revenue (US$ Mn)
12.2. North
America Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Type
12.2.1. Artificial
Cornea
12.2.2. Human
Cornea
12.3. North
America Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Disease Indication
12.3.1. Keratoconus
12.3.2. Myopia
12.3.3. Fuchs'
Dystrophy
12.3.4. Infectious
Cornea
12.3.5. Others
12.4. North
America Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Procedure
Type
12.4.1. Penetrating
Keratoplasty (PK)
12.4.2. Endothelial
Keratoplasty (EK)
12.5. North
America Corneal Implants Market Revenue (US$ Mn) and Forecasts, By End Users
12.5.1. Hospitals
12.5.2. Specialty
Clinics
12.5.3. Ambulatory
Surgical Centers
12.5.4. Others
12.6. North
America Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Country
12.6.1. U.S
12.6.1.1. U.S Corneal Implants Market Revenue (US$ Mn) and Forecasts, By
Type
12.6.1.1.1. Artificial Cornea
12.6.1.1.2. Human Cornea
12.6.1.2. U.S Corneal Implants Market Revenue (US$ Mn) and Forecasts, By
Disease Indication
12.6.1.2.1. Keratoconus
12.6.1.2.2. Myopia
12.6.1.2.3. Fuchs' Dystrophy
12.6.1.2.4. Infectious Cornea
12.6.1.2.5. Others
12.6.1.3. U.S Corneal Implants Market Revenue (US$ Mn) and Forecasts, By
Procedure Type
12.6.1.3.1. Penetrating Keratoplasty (PK)
12.6.1.3.2. Endothelial Keratoplasty (EK)
12.6.1.4. U.S Corneal Implants Market Revenue (US$ Mn) and Forecasts, By
End Users
12.6.1.4.1. Hospitals
12.6.1.4.2. Specialty Clinics
12.6.1.4.3. Ambulatory Surgical Centers
12.6.1.4.4. Others
12.6.2. Canada
12.6.2.1. Canada Corneal Implants Market Revenue (US$ Mn) and Forecasts,
By Type
12.6.2.1.1. Artificial Cornea
12.6.2.1.2. Human Cornea
12.6.2.2. Canada Corneal Implants Market Revenue (US$ Mn) and Forecasts,
By Disease Indication
12.6.2.2.1. Keratoconus
12.6.2.2.2. Myopia
12.6.2.2.3. Fuchs' Dystrophy
12.6.2.2.4. Infectious Cornea
12.6.2.2.5. Others
12.6.2.3. Canada Corneal Implants Market Revenue (US$ Mn) and Forecasts,
By Procedure Type
12.6.2.3.1. Penetrating Keratoplasty (PK)
12.6.2.3.2. Endothelial Keratoplasty (EK)
12.6.2.4. Canada Corneal Implants Market Revenue (US$ Mn) and Forecasts,
By End Users
12.6.2.4.1. Hospitals
12.6.2.4.2. Specialty Clinics
12.6.2.4.3. Ambulatory Surgical Centers
12.6.2.4.4. Others
12.6.3. Mexico
12.6.3.1. Mexico Corneal Implants Market Revenue (US$ Mn) and Forecasts,
By Type
12.6.3.1.1. Artificial Cornea
12.6.3.1.2. Human Cornea
12.6.3.2. Mexico Corneal Implants Market Revenue (US$ Mn) and Forecasts,
By Disease Indication
12.6.3.2.1. Keratoconus
12.6.3.2.2. Myopia
12.6.3.2.3. Fuchs' Dystrophy
12.6.3.2.4. Infectious Cornea
12.6.3.2.5. Others
12.6.3.3. Mexico Corneal Implants Market Revenue (US$ Mn) and Forecasts,
By Procedure Type
12.6.3.3.1. Penetrating Keratoplasty (PK)
12.6.3.3.2. Endothelial Keratoplasty (EK)
12.6.3.4. Mexico Corneal Implants Market Revenue (US$ Mn) and Forecasts,
By End Users
12.6.3.4.1. Hospitals
12.6.3.4.2. Specialty Clinics
12.6.3.4.3. Ambulatory Surgical Centers
12.6.3.4.4. Others
12.6.4. Rest of
North America
12.6.4.1. Rest of North America Corneal Implants Market Revenue (US$ Mn)
and Forecasts, By Type
12.6.4.1.1. Artificial Cornea
12.6.4.1.2. Human Cornea
12.6.4.2. Rest of North America Corneal Implants Market Revenue (US$ Mn)
and Forecasts, By Disease Indication
12.6.4.2.1. Keratoconus
12.6.4.2.2. Myopia
12.6.4.2.3. Fuchs' Dystrophy
12.6.4.2.4. Infectious Cornea
12.6.4.2.5. Others
12.6.4.3. Rest of North America Corneal Implants Market Revenue (US$ Mn)
and Forecasts, By Procedure Type
12.6.4.3.1. Penetrating Keratoplasty (PK)
12.6.4.3.2. Endothelial Keratoplasty (EK)
12.6.4.4. Rest of North America Corneal Implants Market Revenue (US$ Mn)
and Forecasts, By End Users
12.6.4.4.1. Hospitals
12.6.4.4.2. Specialty Clinics
12.6.4.4.3. Ambulatory Surgical Centers
12.6.4.4.4. Others
12.7. Key
Segment for Channeling Investments
12.7.1. By
Country
12.7.2. By Type
12.7.3. By
Disease Indication
12.7.4. By
Procedure Type
12.7.5. By End
Users
13. Europe Corneal Implants Market Analysis and Forecasts, 2021 -
2029
13.1. Overview
13.1.1. Europe
Corneal Implants Market Revenue (US$ Mn)
13.2. Europe
Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Type
13.2.1. Artificial
Cornea
13.2.2. Human
Cornea
13.3. Europe
Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Disease Indication
13.3.1. Keratoconus
13.3.2. Myopia
13.3.3. Fuchs'
Dystrophy
13.3.4. Infectious
Cornea
13.3.5. Others
13.4. Europe Corneal
Implants Market Revenue (US$ Mn) and Forecasts, By Procedure Type
13.4.1. Penetrating
Keratoplasty (PK)
13.4.2. Endothelial
Keratoplasty (EK)
13.5. Europe
Corneal Implants Market Revenue (US$ Mn) and Forecasts, By End Users
13.5.1. Hospitals
13.5.2. Specialty
Clinics
13.5.3. Ambulatory
Surgical Centers
13.5.4. Others
13.6. Europe
Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Country
13.6.1. France
13.6.1.1. France Corneal Implants Market Revenue (US$ Mn) and Forecasts,
By Type
13.6.1.1.1. Artificial Cornea
13.6.1.1.2. Human Cornea
13.6.1.2. France Corneal Implants Market Revenue (US$ Mn) and Forecasts,
By Disease Indication
13.6.1.2.1. Keratoconus
13.6.1.2.2. Myopia
13.6.1.2.3. Fuchs' Dystrophy
13.6.1.2.4. Infectious Cornea
13.6.1.2.5. Others
13.6.1.3. France Corneal Implants Market Revenue (US$ Mn) and Forecasts,
By Procedure Type
13.6.1.3.1. Penetrating Keratoplasty (PK)
13.6.1.3.2. Endothelial Keratoplasty (EK)
13.6.1.4. France Corneal Implants Market Revenue (US$ Mn) and Forecasts,
By End Users
13.6.1.4.1. Hospitals
13.6.1.4.2. Specialty Clinics
13.6.1.4.3. Ambulatory Surgical Centers
13.6.1.4.4. Others
13.6.2. The UK
13.6.2.1. The UK Corneal Implants Market Revenue (US$ Mn) and Forecasts,
By Type
13.6.2.1.1. Artificial Cornea
13.6.2.1.2. Human Cornea
13.6.2.2. The UK Corneal Implants Market Revenue (US$ Mn) and Forecasts,
By Disease Indication
13.6.2.2.1. Keratoconus
13.6.2.2.2. Myopia
13.6.2.2.3. Fuchs' Dystrophy
13.6.2.2.4. Infectious Cornea
13.6.2.2.5. Others
13.6.2.3. The UK Corneal Implants Market Revenue (US$ Mn) and Forecasts,
By Procedure Type
13.6.2.3.1. Penetrating Keratoplasty (PK)
13.6.2.3.2. Endothelial Keratoplasty (EK)
13.6.2.4. The UK Corneal Implants Market Revenue (US$ Mn) and Forecasts,
By End Users
13.6.2.4.1. Hospitals
13.6.2.4.2. Specialty Clinics
13.6.2.4.3. Ambulatory Surgical Centers
13.6.2.4.4. Others
13.6.3. Spain
13.6.3.1. Spain Corneal Implants Market Revenue (US$ Mn) and Forecasts,
By Type
13.6.3.1.1. Artificial Cornea
13.6.3.1.2. Human Cornea
13.6.3.2. Spain Corneal Implants Market Revenue (US$ Mn) and Forecasts,
By Disease Indication
13.6.3.2.1. Keratoconus
13.6.3.2.2. Myopia
13.6.3.2.3. Fuchs' Dystrophy
13.6.3.2.4. Infectious Cornea
13.6.3.2.5. Others
13.6.3.3. Spain Corneal Implants Market Revenue (US$ Mn) and Forecasts,
By Procedure Type
13.6.3.3.1. Penetrating Keratoplasty (PK)
13.6.3.3.2. Endothelial Keratoplasty (EK)
13.6.3.4. Spain Corneal Implants Market Revenue (US$ Mn) and Forecasts,
By End Users
13.6.3.4.1. Hospitals
13.6.3.4.2. Specialty Clinics
13.6.3.4.3. Ambulatory Surgical Centers
13.6.3.4.4. Others
13.6.4. Germany
13.6.4.1. Germany Corneal Implants Market Revenue (US$ Mn) and
Forecasts, By Type
13.6.4.1.1. Artificial Cornea
13.6.4.1.2. Human Cornea
13.6.4.2. Germany Corneal Implants Market Revenue (US$ Mn) and
Forecasts, By Disease Indication
13.6.4.2.1. Keratoconus
13.6.4.2.2. Myopia
13.6.4.2.3. Fuchs' Dystrophy
13.6.4.2.4. Infectious Cornea
13.6.4.2.5. Others
13.6.4.3. Germany Corneal Implants Market Revenue (US$ Mn) and
Forecasts, By Procedure Type
13.6.4.3.1. Penetrating Keratoplasty (PK)
13.6.4.3.2. Endothelial Keratoplasty (EK)
13.6.4.4. Germany Corneal Implants Market Revenue (US$ Mn) and
Forecasts, By End Users
13.6.4.4.1. Hospitals
13.6.4.4.2. Specialty Clinics
13.6.4.4.3. Ambulatory Surgical Centers
13.6.4.4.4. Others
13.6.5. Italy
13.6.5.1. Italy Corneal Implants Market Revenue (US$ Mn) and Forecasts,
By Type
13.6.5.1.1. Artificial Cornea
13.6.5.1.2. Human Cornea
13.6.5.2. Italy Corneal Implants Market Revenue (US$ Mn) and Forecasts,
By Disease Indication
13.6.5.2.1. Keratoconus
13.6.5.2.2. Myopia
13.6.5.2.3. Fuchs' Dystrophy
13.6.5.2.4. Infectious Cornea
13.6.5.2.5. Others
13.6.5.3. Italy Corneal Implants Market Revenue (US$ Mn) and Forecasts,
By Procedure Type
13.6.5.3.1. Penetrating Keratoplasty (PK)
13.6.5.3.2. Endothelial Keratoplasty (EK)
13.6.5.4. Italy Corneal Implants Market Revenue (US$ Mn) and Forecasts,
By End Users
13.6.5.4.1. Hospitals
13.6.5.4.2. Specialty Clinics
13.6.5.4.3. Ambulatory Surgical Centers
13.6.5.4.4. Others
13.6.6. Nordic
Countries
13.6.6.1. Nordic Countries Corneal Implants Market Revenue (US$ Mn) and
Forecasts, By Type
13.6.6.1.1. Artificial Cornea
13.6.6.1.2. Human Cornea
13.6.6.2. Nordic Countries Corneal Implants Market Revenue (US$ Mn) and
Forecasts, By Disease Indication
13.6.6.2.1. Keratoconus
13.6.6.2.2. Myopia
13.6.6.2.3. Fuchs' Dystrophy
13.6.6.2.4. Infectious Cornea
13.6.6.2.5. Others
13.6.6.3. Nordic Countries Corneal Implants Market Revenue (US$ Mn) and
Forecasts, By Procedure Type
13.6.6.3.1. Penetrating Keratoplasty (PK)
13.6.6.3.2. Endothelial Keratoplasty (EK)
13.6.6.4. Nordic Countries Corneal Implants Market Revenue (US$ Mn) and
Forecasts, By End Users
13.6.6.4.1. Hospitals
13.6.6.4.2. Specialty Clinics
13.6.6.4.3. Ambulatory Surgical Centers
13.6.6.4.4. Others
13.6.6.5. Nordic Countries Corneal Implants Market Revenue (US$ Mn) and
Forecasts, By Country
13.6.6.5.1. Denmark
13.6.6.5.2. Finland
13.6.6.5.3. Iceland
13.6.6.5.4. Sweden
13.6.6.5.5. Norway
13.6.7. Benelux
Union
13.6.7.1. Benelux Union Corneal Implants Market Revenue (US$ Mn) and
Forecasts, By Type
13.6.7.1.1. Artificial Cornea
13.6.7.1.2. Human Cornea
13.6.7.2. Benelux Union Corneal Implants Market Revenue (US$ Mn) and
Forecasts, By Disease Indication
13.6.7.2.1. Keratoconus
13.6.7.2.2. Myopia
13.6.7.2.3. Fuchs' Dystrophy
13.6.7.2.4. Infectious Cornea
13.6.7.2.5. Others
13.6.7.3. Benelux Union Corneal Implants Market Revenue (US$ Mn) and
Forecasts, By Procedure Type
13.6.7.3.1. Penetrating Keratoplasty (PK)
13.6.7.3.2. Endothelial Keratoplasty (EK)
13.6.7.4. Benelux Union Corneal Implants Market Revenue (US$ Mn) and
Forecasts, By End Users
13.6.7.4.1. Hospitals
13.6.7.4.2. Specialty Clinics
13.6.7.4.3. Ambulatory Surgical Centers
13.6.7.4.4. Others
13.6.7.5. Benelux Union Corneal Implants Market Revenue (US$ Mn) and
Forecasts, By Country
13.6.7.5.1. Belgium
13.6.7.5.2. The Netherlands
13.6.7.5.3. Luxembourg
13.6.8. Rest of
Europe
13.6.8.1. Rest of Europe Corneal Implants Market Revenue (US$ Mn) and
Forecasts, By Type
13.6.8.1.1. Artificial Cornea
13.6.8.1.2. Human Cornea
13.6.8.2. Rest of Europe Corneal Implants Market Revenue (US$ Mn) and
Forecasts, By Disease Indication
13.6.8.2.1. Keratoconus
13.6.8.2.2. Myopia
13.6.8.2.3. Fuchs' Dystrophy
13.6.8.2.4. Infectious Cornea
13.6.8.2.5. Others
13.6.8.3. Rest of Europe Corneal Implants Market Revenue (US$ Mn) and
Forecasts, By Procedure Type
13.6.8.3.1. Penetrating Keratoplasty (PK)
13.6.8.3.2. Endothelial Keratoplasty (EK)
13.6.8.4. Rest of Europe Corneal Implants Market Revenue (US$ Mn) and
Forecasts, By End Users
13.6.8.4.1. Hospitals
13.6.8.4.2. Specialty Clinics
13.6.8.4.3. Ambulatory Surgical Centers
13.6.8.4.4. Others
13.7. Key
Segment for Channeling Investments
13.7.1. By
Country
13.7.2. By Type
13.7.3. By Disease
Indication
13.7.4. By
Procedure Type
13.7.5. By End
Users
14. Asia Pacific Corneal Implants Market Analysis and Forecasts,
2021 - 2029
14.1. Overview
14.1.1. Asia
Pacific Corneal Implants Market Revenue (US$ Mn)
14.2. Asia
Pacific Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Type
14.2.1. Artificial
Cornea
14.2.2. Human
Cornea
14.3. Asia
Pacific Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Disease
Indication
14.3.1. Keratoconus
14.3.2. Myopia
14.3.3. Fuchs'
Dystrophy
14.3.4. Infectious
Cornea
14.3.5. Others
14.4. Asia
Pacific Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Procedure
Type
14.4.1. Penetrating
Keratoplasty (PK)
14.4.2. Endothelial
Keratoplasty (EK)
14.5. Asia
Pacific Corneal Implants Market Revenue (US$ Mn) and Forecasts, By End Users
14.5.1. Hospitals
14.5.2. Specialty
Clinics
14.5.3. Ambulatory
Surgical Centers
14.5.4. Others
14.6. Asia
Pacific Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Country
14.6.1. China
14.6.1.1. China Corneal Implants Market Revenue (US$ Mn) and Forecasts,
By Type
14.6.1.1.1. Artificial Cornea
14.6.1.1.2. Human Cornea
14.6.1.2. China Corneal Implants Market Revenue (US$ Mn) and Forecasts,
By Disease Indication
14.6.1.2.1. Keratoconus
14.6.1.2.2. Myopia
14.6.1.2.3. Fuchs' Dystrophy
14.6.1.2.4. Infectious Cornea
14.6.1.2.5. Others
14.6.1.3. China Corneal Implants Market Revenue (US$ Mn) and Forecasts,
By Procedure Type
14.6.1.3.1. Penetrating Keratoplasty (PK)
14.6.1.3.2. Endothelial Keratoplasty (EK)
14.6.1.4. China Corneal Implants Market Revenue (US$ Mn) and Forecasts,
By End Users
14.6.1.4.1. Hospitals
14.6.1.4.2. Specialty Clinics
14.6.1.4.3. Ambulatory Surgical Centers
14.6.1.4.4. Others
14.6.2. Japan
14.6.2.1. Japan Corneal Implants Market Revenue (US$ Mn) and Forecasts,
By Type
14.6.2.1.1. Artificial Cornea
14.6.2.1.2. Human Cornea
14.6.2.2. Japan Corneal Implants Market Revenue (US$ Mn) and Forecasts,
By Disease Indication
14.6.2.2.1. Keratoconus
14.6.2.2.2. Myopia
14.6.2.2.3. Fuchs' Dystrophy
14.6.2.2.4. Infectious Cornea
14.6.2.2.5. Others
14.6.2.3. Japan Corneal Implants Market Revenue (US$ Mn) and Forecasts,
By Procedure Type
14.6.2.3.1. Penetrating Keratoplasty (PK)
14.6.2.3.2. Endothelial Keratoplasty (EK)
14.6.2.4. Japan Corneal Implants Market Revenue (US$ Mn) and Forecasts,
By End Users
14.6.2.4.1. Hospitals
14.6.2.4.2. Specialty Clinics
14.6.2.4.3. Ambulatory Surgical Centers
14.6.2.4.4. Others
14.6.3. India
14.6.3.1. India Corneal Implants Market Revenue (US$ Mn) and Forecasts,
By Type
14.6.3.1.1. Artificial Cornea
14.6.3.1.2. Human Cornea
14.6.3.2. India Corneal Implants Market Revenue (US$ Mn) and Forecasts,
By Disease Indication
14.6.3.2.1. Keratoconus
14.6.3.2.2. Myopia
14.6.3.2.3. Fuchs' Dystrophy
14.6.3.2.4. Infectious Cornea
14.6.3.2.5. Others
14.6.3.3. India Corneal Implants Market Revenue (US$ Mn) and Forecasts,
By Procedure Type
14.6.3.3.1. Penetrating Keratoplasty (PK)
14.6.3.3.2. Endothelial Keratoplasty (EK)
14.6.3.4. India Corneal Implants Market Revenue (US$ Mn) and Forecasts,
By End Users
14.6.3.4.1. Hospitals
14.6.3.4.2. Specialty Clinics
14.6.3.4.3. Ambulatory Surgical Centers
14.6.3.4.4. Others
14.6.4. New
Zealand
14.6.4.1. New Zealand Corneal Implants Market Revenue (US$ Mn) and
Forecasts, By Type
14.6.4.1.1. Artificial Cornea
14.6.4.1.2. Human Cornea
14.6.4.2. New Zealand Corneal Implants Market Revenue (US$ Mn) and
Forecasts, By Disease Indication
14.6.4.2.1. Keratoconus
14.6.4.2.2. Myopia
14.6.4.2.3. Fuchs' Dystrophy
14.6.4.2.4. Infectious Cornea
14.6.4.2.5. Others
14.6.4.3. New Zealand Corneal Implants Market Revenue (US$ Mn) and
Forecasts, By Procedure Type
14.6.4.3.1. Penetrating Keratoplasty (PK)
14.6.4.3.2. Endothelial Keratoplasty (EK)
14.6.4.4. New Zealand Corneal Implants Market Revenue (US$ Mn) and
Forecasts, By End Users
14.6.4.4.1. Hospitals
14.6.4.4.2. Specialty Clinics
14.6.4.4.3. Ambulatory Surgical Centers
14.6.4.4.4. Others
14.6.5. Australia
14.6.5.1. Australia Corneal Implants Market Revenue (US$ Mn) and
Forecasts, By Type
14.6.5.1.1. Artificial Cornea
14.6.5.1.2. Human Cornea
14.6.5.2. Australia Corneal Implants Market Revenue (US$ Mn) and
Forecasts, By Disease Indication
14.6.5.2.1. Keratoconus
14.6.5.2.2. Myopia
14.6.5.2.3. Fuchs' Dystrophy
14.6.5.2.4. Infectious Cornea
14.6.5.2.5. Others
14.6.5.3. Australia Corneal Implants Market Revenue (US$ Mn) and
Forecasts, By Procedure Type
14.6.5.3.1. Penetrating Keratoplasty (PK)
14.6.5.3.2. Endothelial Keratoplasty (EK)
14.6.5.4. Australia Corneal Implants Market Revenue (US$ Mn) and
Forecasts, By End Users
14.6.5.4.1. Hospitals
14.6.5.4.2. Specialty Clinics
14.6.5.4.3. Ambulatory Surgical Centers
14.6.5.4.4. Others
14.6.6. South
Korea
14.6.6.1. South Korea Corneal Implants Market Revenue (US$ Mn) and
Forecasts, By Type
14.6.6.1.1. Artificial Cornea
14.6.6.1.2. Human Cornea
14.6.6.2. South Korea Corneal Implants Market Revenue (US$ Mn) and
Forecasts, By Disease Indication
14.6.6.2.1. Keratoconus
14.6.6.2.2. Myopia
14.6.6.2.3. Fuchs' Dystrophy
14.6.6.2.4. Infectious Cornea
14.6.6.2.5. Others
14.6.6.3. South Korea Corneal Implants Market Revenue (US$ Mn) and
Forecasts, By Procedure Type
14.6.6.3.1. Penetrating Keratoplasty (PK)
14.6.6.3.2. Endothelial Keratoplasty (EK)
14.6.6.4. South Korea Corneal Implants Market Revenue (US$ Mn) and
Forecasts, By End Users
14.6.6.4.1. Hospitals
14.6.6.4.2. Specialty Clinics
14.6.6.4.3. Ambulatory Surgical Centers
14.6.6.4.4. Others
14.6.7. Southeast
Asia
14.6.7.1. Southeast Asia Corneal Implants Market Revenue (US$ Mn) and
Forecasts, By Type
14.6.7.1.1. Artificial Cornea
14.6.7.1.2. Human Cornea
14.6.7.2. Southeast Asia Corneal Implants Market Revenue (US$ Mn) and
Forecasts, By Disease Indication
14.6.7.2.1. Keratoconus
14.6.7.2.2. Myopia
14.6.7.2.3. Fuchs' Dystrophy
14.6.7.2.4. Infectious Cornea
14.6.7.2.5. Others
14.6.7.3. Southeast Asia Corneal Implants Market Revenue (US$ Mn) and
Forecasts, By Procedure Type
14.6.7.3.1. Penetrating Keratoplasty (PK)
14.6.7.3.2. Endothelial Keratoplasty (EK)
14.6.7.4. Southeast Asia Corneal Implants Market Revenue (US$ Mn) and
Forecasts, By End Users
14.6.7.4.1. Hospitals
14.6.7.4.2. Specialty Clinics
14.6.7.4.3. Ambulatory Surgical Centers
14.6.7.4.4. Others
14.6.7.5. Southeast Asia Corneal Implants Market Revenue (US$ Mn) and
Forecasts, By Country
14.6.7.5.1. Indonesia
14.6.7.5.2. Thailand
14.6.7.5.3. Malaysia
14.6.7.5.4. Singapore
14.6.7.5.5. Rest of Southeast Asia
14.6.8. Rest of
Asia Pacific
14.6.8.1. Rest of Asia Pacific Corneal Implants Market Revenue (US$ Mn)
and Forecasts, By Type
14.6.8.1.1. Artificial Cornea
14.6.8.1.2. Human Cornea
14.6.8.2. Rest of Asia Pacific Corneal Implants Market Revenue (US$ Mn)
and Forecasts, By Disease Indication
14.6.8.2.1. Keratoconus
14.6.8.2.2. Myopia
14.6.8.2.3. Fuchs' Dystrophy
14.6.8.2.4. Infectious Cornea
14.6.8.2.5. Others
14.6.8.3. Rest of Asia Pacific Corneal Implants Market Revenue (US$ Mn)
and Forecasts, By Procedure Type
14.6.8.3.1. Penetrating Keratoplasty (PK)
14.6.8.3.2. Endothelial Keratoplasty (EK)
14.6.8.4. Rest of Asia Pacific Corneal Implants Market Revenue (US$ Mn)
and Forecasts, By End Users
14.6.8.4.1. Hospitals
14.6.8.4.2. Specialty Clinics
14.6.8.4.3. Ambulatory Surgical Centers
14.6.8.4.4. Others
14.7. Key
Segment for Channeling Investments
14.7.1. By
Country
14.7.2. By Type
14.7.3. By
Disease Indication
14.7.4. By
Procedure Type
14.7.5. By End
Users
15. Middle East and Africa Corneal Implants Market Analysis and
Forecasts, 2021 - 2029
15.1. Overview
15.1.1. Middle
East and Africa Corneal Implants Market Revenue (US$ Mn)
15.2. Middle
East and Africa Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Type
15.2.1. Artificial
Cornea
15.2.2. Human
Cornea
15.3. Middle
East and Africa Corneal Implants Market Revenue (US$ Mn) and Forecasts, By
Disease Indication
15.3.1. Keratoconus
15.3.2. Myopia
15.3.3. Fuchs'
Dystrophy
15.3.4. Infectious
Cornea
15.3.5. Others
15.4. Middle
East and Africa Corneal Implants Market Revenue (US$ Mn) and Forecasts, By
Procedure Type
15.4.1. Penetrating
Keratoplasty (PK)
15.4.2. Endothelial
Keratoplasty (EK)
15.5. Middle
East and Africa Corneal Implants Market Revenue (US$ Mn) and Forecasts, By End
Users
15.5.1. Hospitals
15.5.2. Specialty
Clinics
15.5.3. Ambulatory
Surgical Centers
15.5.4. Others
15.6. Middle
East and Africa Corneal Implants Market Revenue (US$ Mn) and Forecasts, By
Country
15.6.1. Saudi
Arabia
15.6.1.1. Saudi Arabia Corneal Implants Market Revenue (US$ Mn) and
Forecasts, By Type
15.6.1.1.1. Artificial Cornea
15.6.1.1.2. Human Cornea
15.6.1.2. Saudi Arabia Corneal Implants Market Revenue (US$ Mn) and
Forecasts, By Disease Indication
15.6.1.2.1. Keratoconus
15.6.1.2.2. Myopia
15.6.1.2.3. Fuchs' Dystrophy
15.6.1.2.4. Infectious Cornea
15.6.1.2.5. Others
15.6.1.3. Saudi Arabia Corneal Implants Market Revenue (US$ Mn) and
Forecasts, By Procedure Type
15.6.1.3.1. Penetrating Keratoplasty (PK)
15.6.1.3.2. Endothelial Keratoplasty (EK)
15.6.1.4. Saudi Arabia Corneal Implants Market Revenue (US$ Mn) and
Forecasts, By End Users
15.6.1.4.1. Hospitals
15.6.1.4.2. Specialty Clinics
15.6.1.4.3. Ambulatory Surgical Centers
15.6.1.4.4. Others
15.6.2. UAE
15.6.2.1. UAE Corneal Implants Market Revenue (US$ Mn) and Forecasts, By
Type
15.6.2.1.1. Artificial Cornea
15.6.2.1.2. Human Cornea
15.6.2.2. UAE Corneal Implants Market Revenue (US$ Mn) and Forecasts, By
Disease Indication
15.6.2.2.1. Keratoconus
15.6.2.2.2. Myopia
15.6.2.2.3. Fuchs' Dystrophy
15.6.2.2.4. Infectious Cornea
15.6.2.2.5. Others
15.6.2.3. UAE Corneal Implants Market Revenue (US$ Mn) and Forecasts, By
Procedure Type
15.6.2.3.1. Penetrating Keratoplasty (PK)
15.6.2.3.2. Endothelial Keratoplasty (EK)
15.6.2.4. UAE Corneal Implants Market Revenue (US$ Mn) and Forecasts, By
End Users
15.6.2.4.1. Hospitals
15.6.2.4.2. Specialty Clinics
15.6.2.4.3. Ambulatory Surgical Centers
15.6.2.4.4. Others
15.6.3. Egypt
15.6.3.1. Egypt Corneal Implants Market Revenue (US$ Mn) and Forecasts,
By Type
15.6.3.1.1. Artificial Cornea
15.6.3.1.2. Human Cornea
15.6.3.2. Egypt Corneal Implants Market Revenue (US$ Mn) and Forecasts,
By Disease Indication
15.6.3.2.1. Keratoconus
15.6.3.2.2. Myopia
15.6.3.2.3. Fuchs' Dystrophy
15.6.3.2.4. Infectious Cornea
15.6.3.2.5. Others
15.6.3.3. Egypt Corneal Implants Market Revenue (US$ Mn) and Forecasts,
By Procedure Type
15.6.3.3.1. Penetrating Keratoplasty (PK)
15.6.3.3.2. Endothelial Keratoplasty (EK)
15.6.3.4. Egypt Corneal Implants Market Revenue (US$ Mn) and Forecasts,
By End Users
15.6.3.4.1. Hospitals
15.6.3.4.2. Specialty Clinics
15.6.3.4.3. Ambulatory Surgical Centers
15.6.3.4.4. Others
15.6.4. Kuwait
15.6.4.1. Kuwait Corneal Implants Market Revenue (US$ Mn) and Forecasts,
By Type
15.6.4.1.1. Artificial Cornea
15.6.4.1.2. Human Cornea
15.6.4.2. Kuwait Corneal Implants Market Revenue (US$ Mn) and Forecasts,
By Disease Indication
15.6.4.2.1. Keratoconus
15.6.4.2.2. Myopia
15.6.4.2.3. Fuchs' Dystrophy
15.6.4.2.4. Infectious Cornea
15.6.4.2.5. Others
15.6.4.3. Kuwait Corneal Implants Market Revenue (US$ Mn) and Forecasts,
By Procedure Type
15.6.4.3.1. Penetrating Keratoplasty (PK)
15.6.4.3.2. Endothelial Keratoplasty (EK)
15.6.4.4. Kuwait Corneal Implants Market Revenue (US$ Mn) and Forecasts,
By End Users
15.6.4.4.1. Hospitals
15.6.4.4.2. Specialty Clinics
15.6.4.4.3. Ambulatory Surgical Centers
15.6.4.4.4. Others
15.6.5. South
Africa
15.6.5.1. South Africa Corneal Implants Market Revenue (US$ Mn) and
Forecasts, By Type
15.6.5.1.1. Artificial Cornea
15.6.5.1.2. Human Cornea
15.6.5.2. South Africa Corneal Implants Market Revenue (US$ Mn) and
Forecasts, By Disease Indication
15.6.5.2.1. Keratoconus
15.6.5.2.2. Myopia
15.6.5.2.3. Fuchs' Dystrophy
15.6.5.2.4. Infectious Cornea
15.6.5.2.5. Others
15.6.5.3. South Africa Corneal Implants Market Revenue (US$ Mn) and
Forecasts, By Procedure Type
15.6.5.3.1. Penetrating Keratoplasty (PK)
15.6.5.3.2. Endothelial Keratoplasty (EK)
15.6.5.4. South Africa Corneal Implants Market Revenue (US$ Mn) and
Forecasts, By End Users
15.6.5.4.1. Hospitals
15.6.5.4.2. Specialty Clinics
15.6.5.4.3. Ambulatory Surgical Centers
15.6.5.4.4. Others
15.6.6. Rest of
Middle East & Africa
15.6.6.1. Rest of Middle East & Africa Corneal Implants Market
Revenue (US$ Mn) and Forecasts, By Type
15.6.6.1.1. Artificial Cornea
15.6.6.1.2. Human Cornea
15.6.6.2. Rest of Middle East & Africa Corneal Implants Market
Revenue (US$ Mn) and Forecasts, By Disease Indication
15.6.6.2.1. Keratoconus
15.6.6.2.2. Myopia
15.6.6.2.3. Fuchs' Dystrophy
15.6.6.2.4. Infectious Cornea
15.6.6.2.5. Others
15.6.6.3. Rest of Middle East & Africa Corneal Implants Market
Revenue (US$ Mn) and Forecasts, By Procedure Type
15.6.6.3.1. Penetrating Keratoplasty (PK)
15.6.6.3.2. Endothelial Keratoplasty (EK)
15.6.6.4. Rest of Middle East & Africa Corneal Implants Market
Revenue (US$ Mn) and Forecasts, By End Users
15.6.6.4.1. Hospitals
15.6.6.4.2. Specialty Clinics
15.6.6.4.3. Ambulatory Surgical Centers
15.6.6.4.4. Others
15.7. Key
Segment for Channeling Investments
15.7.1. By
Country
15.7.2. By Type
15.7.3. By
Disease Indication
15.7.4. By
Procedure Type
15.7.5. By End
Users
16. Latin America Corneal Implants Market Analysis and Forecasts,
2021 - 2029
16.1. Overview
16.1.1. Latin
America Corneal Implants Market Revenue (US$ Mn)
16.2. Latin
America Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Type
16.2.1. Artificial
Cornea
16.2.2. Human
Cornea
16.3. Latin
America Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Disease
Indication
16.3.1. Keratoconus
16.3.2. Myopia
16.3.3. Fuchs'
Dystrophy
16.3.4. Infectious
Cornea
16.3.5. Others
16.4. Latin
America Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Procedure
Type
16.4.1. Penetrating
Keratoplasty (PK)
16.4.2. Endothelial
Keratoplasty (EK)
16.5. Latin
America Corneal Implants Market Revenue (US$ Mn) and Forecasts, By End Users
16.5.1. Hospitals
16.5.2. Specialty
Clinics
16.5.3. Ambulatory
Surgical Centers
16.5.4. Others
16.6. Latin
America Corneal Implants Market Revenue (US$ Mn) and Forecasts, By Country
16.6.1. Brazil
16.6.1.1. Brazil Corneal Implants Market Revenue (US$ Mn) and Forecasts,
By Type
16.6.1.1.1. Artificial Cornea
16.6.1.1.2. Human Cornea
16.6.1.2. Brazil Corneal Implants Market Revenue (US$ Mn) and Forecasts,
By Disease Indication
16.6.1.2.1. Keratoconus
16.6.1.2.2. Myopia
16.6.1.2.3. Fuchs' Dystrophy
16.6.1.2.4. Infectious Cornea
16.6.1.2.5. Others
16.6.1.3. Brazil Corneal Implants Market Revenue (US$ Mn) and Forecasts,
By Procedure Type
16.6.1.3.1. Penetrating Keratoplasty (PK)
16.6.1.3.2. Endothelial Keratoplasty (EK)
16.6.1.4. Brazil Corneal Implants Market Revenue (US$ Mn) and Forecasts,
By End Users
16.6.1.4.1. Hospitals
16.6.1.4.2. Specialty Clinics
16.6.1.4.3. Ambulatory Surgical Centers
16.6.1.4.4. Others
16.6.2. Argentina
16.6.2.1. Argentina Corneal Implants Market Revenue (US$ Mn) and
Forecasts, By Type
16.6.2.1.1. Artificial Cornea
16.6.2.1.2. Human Cornea
16.6.2.2. Argentina Corneal Implants Market Revenue (US$ Mn) and
Forecasts, By Disease Indication
16.6.2.2.1. Keratoconus
16.6.2.2.2. Myopia
16.6.2.2.3. Fuchs' Dystrophy
16.6.2.2.4. Infectious Cornea
16.6.2.2.5. Others
16.6.2.3. Argentina Corneal Implants Market Revenue (US$ Mn) and
Forecasts, By Procedure Type
16.6.2.3.1. Penetrating Keratoplasty (PK)
16.6.2.3.2. Endothelial Keratoplasty (EK)
16.6.2.4. Argentina Corneal Implants Market Revenue (US$ Mn) and
Forecasts, By End Users
16.6.2.4.1. Hospitals
16.6.2.4.2. Specialty Clinics
16.6.2.4.3. Ambulatory Surgical Centers
16.6.2.4.4. Others
16.6.3. Rest of
Latin America
16.6.3.1. Rest of Latin America Corneal Implants Market Revenue (US$ Mn)
and Forecasts, By Type
16.6.3.1.1. Artificial Cornea
16.6.3.1.2. Human Cornea
16.6.3.2. Rest of Latin America Corneal Implants Market Revenue (US$ Mn)
and Forecasts, By Disease Indication
16.6.3.2.1. Keratoconus
16.6.3.2.2. Myopia
16.6.3.2.3. Fuchs' Dystrophy
16.6.3.2.4. Infectious Cornea
16.6.3.2.5. Others
16.6.3.3. Rest of Latin America Corneal Implants Market Revenue (US$ Mn)
and Forecasts, By Procedure Type
16.6.3.3.1. Penetrating Keratoplasty (PK)
16.6.3.3.2. Endothelial Keratoplasty (EK)
16.6.3.4. Rest of Latin America Corneal Implants Market Revenue (US$ Mn)
and Forecasts, By End Users
16.6.3.4.1. Hospitals
16.6.3.4.2. Specialty Clinics
16.6.3.4.3. Ambulatory Surgical Centers
16.6.3.4.4. Others
16.7. Key
Segment for Channeling Investments
16.7.1. By
Country
16.7.2. By Type
16.7.3. By
Disease Indication
16.7.4. By
Procedure Type
16.7.5. By End
Users
17. Competitive Benchmarking
17.1. Market
Share Analysis, 2020
17.2. Global Presence
and Growth Strategies
17.2.1. Mergers
and Acquisitions
17.2.2. Product
Launches
17.2.3. Investments
Trends
17.2.4. R&D
Initiatives
18. Player Profiles
18.1. AJL
Ophthalmic, S.A.
18.1.1. Company
Details
18.1.2. Company
Overview
18.1.3. Product
Offerings
18.1.4. Key
Developments
18.1.5. Financial
Analysis
18.1.6. SWOT
Analysis
18.1.7. Business
Strategies
18.2. Aurolab
18.2.1. Company
Details
18.2.2. Company
Overview
18.2.3. Product
Offerings
18.2.4. Key
Developments
18.2.5. Financial
Analysis
18.2.6. SWOT
Analysis
18.2.7. Business Strategies
18.3. CorneaGen
18.3.1. Company
Details
18.3.2. Company
Overview
18.3.3. Product
Offerings
18.3.4. Key
Developments
18.3.5. Financial
Analysis
18.3.6. SWOT Analysis
18.3.7. Business
Strategies
18.4. CorNeat Vision
18.4.1. Company
Details
18.4.2. Company
Overview
18.4.3. Product
Offerings
18.4.4. Key
Developments
18.4.5. Financial
Analysis
18.4.6. SWOT
Analysis
18.4.7. Business
Strategies
18.5. EyeYon Medical
18.5.1. Company
Details
18.5.2. Company
Overview
18.5.3. Product
Offerings
18.5.4. Key
Developments
18.5.5. Financial
Analysis
18.5.6. SWOT
Analysis
18.5.7. Business
Strategies
18.6. L V PRASAD EYE INSTITUTE
18.6.1. Company
Details
18.6.2. Company
Overview
18.6.3. Product
Offerings
18.6.4. Key
Developments
18.6.5. Financial
Analysis
18.6.6. SWOT
Analysis
18.6.7. Business
Strategies
18.7. LinkoCare Life Sciences AB
18.7.1. Company
Details
18.7.2. Company
Overview
18.7.3. Product
Offerings
18.7.4. Key
Developments
18.7.5. Financial
Analysis
18.7.6. SWOT
Analysis
18.7.7. Business
Strategies
18.8. Presbia PLC
18.8.1. Company
Details
18.8.2. Company
Overview
18.8.3. Product
Offerings
18.8.4. Key
Developments
18.8.5. Financial
Analysis
18.8.6. SWOT
Analysis
18.8.7. Business
Strategies
18.9. SightLife
18.9.1. Company
Details
18.9.2. Company
Overview
18.9.3. Product
Offerings
18.9.4. Key
Developments
18.9.5. Financial
Analysis
18.9.6. SWOT
Analysis
18.9.7. Business
Strategies
18.10. Swissmed Pte Ltd.
18.10.1. Company
Details
18.10.2. Company
Overview
18.10.3. Product
Offerings
18.10.4. Key
Developments
18.10.5. Financial
Analysis
18.10.6. SWOT
Analysis
18.10.7. Business
Strategies
18.11. Other Market Participants
19. Key Findings
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.